Xlife Sciences AG (SWX:XLS)
Switzerland
· Delayed Price · Currency is CHF 20.00
+0.05 (0.25%)
Last updated: Jun 27, 2025
Xlife Sciences AG Market Cap
Xlife Sciences AG has a market cap or net worth of 113.40 million as of June 27, 2025. Its market cap has decreased by -42.53% in one year.
Market Cap
113.40M
Enterprise Value
263.88M
Revenue
834.88K
Ranking
n/a
PE Ratio
4.35
Stock Price
20.00
Market Cap Chart
Since February 10, 2022, Xlife Sciences AG's market cap has decreased from 240.46M to 113.40M, a decrease of -52.84%. That is a compound annual growth rate of -19.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2025 | 111.39M | -23.62% |
| Dec 30, 2024 | 145.84M | -47.72% |
| Dec 29, 2023 | 278.96M | 77.76% |
| Dec 30, 2022 | 156.93M | -34.74% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Roche Holding AG | 208.01B |
| Novartis AG | 186.13B |
| Lonza Group AG | 39.97B |
| Alcon | 34.91B |
| Galderma Group AG | 26.87B |
| Sandoz Group AG | 18.35B |
| Straumann Holding AG | 16.46B |
| Sonova Holding AG | 14.35B |